Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

PDUFA Pending

A quick look at hematologic drugs pending approval by the U.S. Food and Drug Administration
Approval Granted for New Acalabrutinib Indication
February 26, 2025
Fitusiran on the Horizon for Hemophilia
February 26, 2025

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
March 2025

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals